clostridium difficile

Latest Headlines

Latest Headlines

Sanofi launches PhII study of C. diff vaccine

Sanofi Pasteur has launched an ambitious mid-stage clinical trial for an experimental new vaccine that will attempt to thwart the rising risk of hospital-acquired Clostridium difficile infection.

Medarex snares $225M deal for C. diff program

Medarex and Massachusetts Biologic Laboratory will share an upfront payment of $60 million and up to $165 million in milestones from Merck, which is licensing an antibody they discovered for C.

Sanofi launches new trial for dengue fever

Sanofi-Pasteur has launched a clinical trial in Thailand to test a tetravalent vaccine for dengue fever, the world's second most common tropical disease in children. Adding to the urgency for the

Optimer surges on antibiotic data

Optimer Pharmaceuticals' stock surged on news that the company's anti-infective drug OPT-80 outperformed ViroPharma's Vancocin in a late-stage trial. Vancocin is currently the only approved treatment

U.K. expects superbug vaccines within 10 years

The UK's chief medical officer is predicting that new vaccines will be available within five to 10 years that can protect hospital patients against deadly superbugs that kill thousands of people